You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 283 No. 22, June 14, 2000 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA

Effect of Ritonavir on Saquinavir Metabolism

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The Consensus Statement on antiretroviral therapy in adults by Dr Carpenter and colleagues1 contains an inaccuracy regarding the effect of coadministration of ritonavir on the exposure of saquinavir in the soft-gelatin formulation (saquinavir SGF). Table 2 states that ritonavir coadministration results in an increase in saquinavir exposure (area under the plasma concentration curve [AUC]) of 121%. This estimate, however, is too low by greater than an order of magnitude.2

The increase of 121% results from a comparison of the 24-hour saquinavir exposures obtained with the combination of 400 mg of ritonavir twice daily plus 400 mg of saquinavir SGF twice daily against exposures obtained with saquinavir SGF, 1200 mg, administered 3 times daily (the licensed dosage).3-4 This comparison was previously presented because it was considered to be clinically meaningful in view of the wide use of the ritonavir, 400 mg, and saquinavir SGF, 400 mg, twice daily . . . [Full Text of this Article]


RELATED ARTICLE

Antiretroviral Therapy in Adults: Updated Recommendations of the International AIDS Society–USA Panel
Charles C. J. Carpenter, David A. Cooper, Margaret A. Fischl, Jose M. Gatell, Brian G. Gazzard, Scott M. Hammer, Martin S. Hirsch, Donna M. Jacobsen, David A. Katzenstein, Julio S. G. Montaner, Douglas D. Richman, Michael S. Saag, Mauro Schechter, Robert T. Schooley, Melanie A. Thompson, Stefano Vella, Patrick G. Yeni, and Paul A. Volberding
JAMA. 2000;283(3):381-390.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Model-based Analysis of the Pharmacokinetic Interactions Between Ritonavir, Nelfinavir, and Saquinavir after Simultaneous and Staggered Oral Administration
Lu et al.
Drug Metab. Dispos. 2002;30:1455-1461.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.